CompletedNCT00198198
Aripiprazole added to ongoing care for bipolar depression
Medication studyAges 18–65United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- IndianapolisSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Indiana University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00198198
- Official title
Show the full official title
Open Label Pilot Study of Aripiprazole Treatment of Difficult to Treat Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Indianapolis
Questions about this study
Who is behind this study?
The study sponsor is Indiana University, a university.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole.
Who was this study for?
Listed age limits: 18 years to 65 years.
